The engrafted leukaemia revealed the presence of early CD34+CD19+CD10−, intermediate CD34+CD19+CD10+ and late CD34−CD19+CD10+ ALL progenitors that had the capacity to proliferate in vivo. The gene discussed is MME; the disease is leukemia.